%0 Journal Article
%T Paroxysmal atrial fibrillation history is associated with earlier recurrence after first cardioversion compared with primary persistent atrial fibrillation.
%A Rutlen C
%A Mullen C
%A Phan F
%A Raitt M
%A Dalouk K
%A Zarraga I
%A Shim D
%A Jessel PM
%J Heart Rhythm
%V 0
%N 0
%D 2024 Jul 18
%M 39032524
%F 6.779
%R 10.1016/j.hrthm.2024.07.030
%X <B>BACKGROUND: </B>Paroxysmal atrial fibrillation (pAF) may progress through cardiac remodeling to persistent atrial fibrillation (psAF). However, some may present in psAF without a preceding history of pAF. A preceding history of pAF may affect recurrence after direct current cardioversion (DCCV).<BR><B>OBJECTIVE: </B>The aim of this study was to determine whether a preceding history of pAF is associated with a difference in recurrence rates after DCCV compared with patients without a preceding history of pAF.<BR><B>METHODS: </B>A prospective procedural database at a Veterans Affairs center identified 565 patients who underwent their first DCCV for psAF. Initial rhythm history was separated by prior pAF, and those with none were considered primary psAF. Electrocardiography follow-up was standardized at 1 month and 3 months after cardioversion.<BR><B>RESULTS: </B>Patients who underwent their first DCCV for psAF were more likely to have presented with primary psAF (81.6%). Those with pAF had a similar left atrial size but were more likely to have chronic kidney disease, sleep apnea, previous stroke, and use of antiarrhythmic drugs at the time of cardioversion. Patients with pAF had earlier recurrence and shorter median AF survival time, 1.6 months compared with 5 months (Kaplan-Meier plot, P = .0101). This difference persisted in controlling for antiarrhythmic drug use. Recurrence type was mostly persistent AF, similar in both groups.<BR><B>CONCLUSIONS: </B>Patients with primary psAF may have a more sustained response to DCCV compared with those with a preceding history of pAF. Thus, those patients with pAF may benefit from a more aggressive, early rhythm control strategy because of higher likelihood of recurrence with DCCV.